Literature DB >> 12665168

Growth factor regulation of PC4/TIS7, an immediate early gene expressed during gut adaptation after resection.

Elzbieta Swietlicki1, Hristo Iordanov, Christine Fritsch, Lu Yi, Marc S Levin, Deborah C Rubin.   

Abstract

BACKGROUND: To define the molecular mechanisms underlying the intestinal adaptive response after partial small bowel resection, we previously identified a cohort of genes regulated in the remnant adaptive ileum. One is PC4/TIS7, an immediate early gene preferentially up-regulated during the first 48 hours after resection. To further the mechanisms that regulate gut adaptation, we sought to identify upstream regulators of PC4/TIS7 expression.
METHODS: PC4/TIS7 expression in adaptive versus transection control mouse gut was examined at 48 hours after 50% intestinal resection, and its cellular localization was determined by immunohistochemistry. The effects of intestinotrophic peptides and growth factors on PC4/TIS7 expression were examined in vitro in the crypt epithelial cell line IEC 18 and in vivo in the mouse.
RESULTS: PC4/TIS7 was expressed in the cytoplasm of IEC 18 cells and in adaptive mouse ileal crypt and villus enterocytes. Epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) increased PC4/TIS7 mRNA levels in postconfluent, quiescent IEC 18 cells, but insulin-like growth factor 1 (IGF-1) and nerve growth factor (NGF) had no effect. A stable derivative of glucagon-like peptide 2 (GLP-2), r(gly2)GLP-2, was most potent in increasing PC4/TIS7 expression; however, stimulation of proliferation and differentiation were not observed. To determine the effect of GLP-2 on PC4/TIS7 expression in vivo, r(gly2)GLP-2 was administered intraperitoneally to mice. PC4/TIS7 mRNA expression was increased in small bowel in response to GLP-2 compared with vehicle control.
CONCLUSIONS: These results suggest that PC4/TIS7 plays a role in intracellular signaling in the intestinal epithelium during the adaptive response, possibly as a common downstream effector for several intestinotrophic growth factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665168     DOI: 10.1177/0148607103027002123

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  4 in total

1.  Deletion of Tis7 protects mice from high-fat diet-induced weight gain and blunts the intestinal adaptive response postresection.

Authors:  Cong Yu; Shujun Jiang; Jianyun Lu; Carrie C Coughlin; Yuan Wang; Elzbieta A Swietlicki; Lihua Wang; Ilja Vietor; Lukas A Huber; Domagoj Cikes; Trey Coleman; Yan Xie; Clay F Semenkovich; Nicholas O Davidson; Marc S Levin; Deborah C Rubin
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

2.  Increased IFRD1 Expression in Human Colon Cancers Predicts Reduced Patient Survival.

Authors:  Mark A Lewis; Noura Sharabash; Zhi-Feng Miao; Lydia N Lyons; Jay Piccirillo; Donna Kallogjeri; Mario Schootman; Matthew Mutch; Yan Yan; Marc S Levin; Antoni Castells; Miriam Cuatrecasas; Jason C Mills; Zhen-Ning Wang; Deborah C Rubin
Journal:  Dig Dis Sci       Date:  2017-11-01       Impact factor: 3.199

3.  Tis7 deletion reduces survival and induces intestinal anastomotic inflammation and obstruction in high-fat diet-fed mice with short bowel syndrome.

Authors:  Amy M Garcia; Derek Wakeman; Jianyun Lu; Christopher Rowley; Taylor Geisman; Catherine Butler; Shashi Bala; Elzbieta A Swietlicki; Brad W Warner; Marc S Levin; Deborah C Rubin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

Review 4.  Intestinal hormones and growth factors: effects on the small intestine.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.